ISO 17593:2022
p
ISO 17593:2022
79378
Indisponible en français

Résumé

 Preview

This document specifies requirements for in vitro measuring systems for self-monitoring of vitamin-K antagonist oral anticoagulation therapy, including performance, quality assurance and user training and procedures for the validation of performance by the intended users under actual and simulated conditions of use.

This document applies solely to prothrombin time measuring systems used by lay persons for monitoring their own vitamin-K antagonist oral anticoagulation therapy, and which report results as international normalized ratios (INR).

This document is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems.

This document is not applicable to:

—    in vitro measuring systems for coagulation quantities assessing vitamin-K antagonist oral anticoagulation therapy used by physicians or healthcare providers;

—    non-vitamin-K antagonist oral anticoagulation therapy (e.g. dabigatran);

—    a comprehensive evaluation of all possible factors that can affect the performance of these systems;

—    the medical aspects of oral-anticoagulation therapy.


Informations générales 

  •  :  Publiée
     : 2022-03
  •  : 2
  •  : ISO/TC 212 Laboratoires de biologie médicale et systèmes de diagnostic in vitro
  •  :
    11.100.20 Évaluation biologique des dispositifs médicaux

Acheter cette norme

fr
Format Langue
std 1 178 PDF + ePub
std 2 178 Papier
  • CHF178

Cycle de vie


Vous avez une question?

Consulter notre FAQ

Service à la clientèle
+41 22 749 08 88

Horaires d’ouverture:
De lundi à vendredi - 09:00-12:00, 14:00-17:00 (UTC+1)

Suivez l'actualité de l'ISO

Inscrivez-vous à notre Newsletter (en anglais) pour suivre nos actualités, points de vue et informations sur nos produits.